Did You Manage To Avoid Almirall's (BME:ALM) 40% Share Price Drop?

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But every investor is virtually certain to have both over-performing and under-performing stocks. So we wouldn't blame long term Almirall, S.A. (BME:ALM) shareholders for doubting their decision to hold, with the stock down 40% over a half decade. And some of the more recent buyers are probably worried, too, with the stock falling 31% in the last year. Furthermore, it's down 28% in about a quarter. That's not much fun for holders. But this could be related to the weak market, which is down 27% in the same period.

See our latest analysis for Almirall

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

During the five years over which the share price declined, Almirall's earnings per share (EPS) dropped by 25% each year. The share price decline of 9.6% per year isn't as bad as the EPS decline. The relatively muted share price reaction might be because the market expects the business to turn around.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

BME:ALM Past and Future Earnings April 1st 2020
BME:ALM Past and Future Earnings April 1st 2020

We know that Almirall has improved its bottom line lately, but is it going to grow revenue? If you're interested, you could check this free report showing consensus revenue forecasts.

Advertisement

What About Dividends?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. We note that for Almirall the TSR over the last 5 years was -36%, which is better than the share price return mentioned above. This is largely a result of its dividend payments!

A Different Perspective

We regret to report that Almirall shareholders are down 30% for the year (even including dividends) . Unfortunately, that's worse than the broader market decline of 23%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 8.6% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Almirall , and understanding them should be part of your investment process.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on ES exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

About BME:ALM

Almirall

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Flawless balance sheet with solid track record.

Advertisement

Weekly Picks

LO
Lou_Basenese
VTIX logo
Lou_Basenese on Virtuix Holdings ·

From a “Shark Tank” Snub to an Air Force “Yes”: Why Virtuix at $3.50 May Be the Market’s Most Mispriced AI Story

Fair Value:US$7.557.6% undervalued
17 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75034.8% undervalued
63 users have followed this narrative
1 users have commented on this narrative
7 users have liked this narrative
TR
tripledub
INTU logo
tripledub on Intuit ·

A Wonderful Business at a Not-So-Wonderful Price

Fair Value:US$56054.5% undervalued
61 users have followed this narrative
4 users have commented on this narrative
29 users have liked this narrative
TA
Talos
HYFT logo
Talos on MindWalk Holdings ·

The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect

Fair Value:US$8.2781.6% undervalued
33 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

AN
AntonioS
CAR logo
AntonioS on CAR Group ·

CAR Group. A wonderful compounding franchise at a fair-not-cheap price.

Fair Value:AU$3219.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GA
PLTR logo
GaryB on Palantir Technologies ·

Palantir hits 52 week low.

Fair Value:US$274.861.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
NO
EWY logo
North49_ on iShares - iShares MSCI South Korea ETF ·

EWY:US NYSE Arca iShares Msci South Korea ETF, an opportunity to diversify your tech investments.

Fair Value:US$273.4525.0% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9639.6% undervalued
61 users have followed this narrative
9 users have commented on this narrative
18 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7445.2% undervalued
67 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75034.8% undervalued
63 users have followed this narrative
1 users have commented on this narrative
7 users have liked this narrative